Compare
Agilent Technologies, Inc. vs Illumina, Inc. vs Mettler Toledo International Inc vs Bruker Corp
| Latest fiscal year | Agilent Technologies, Inc. A | Illumina, Inc. ILMN | Mettler Toledo International Inc MTD | Bruker Corp BRKR |
|---|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-28 | 2025-12-31 | 2025-12-31 |
| Revenue | $6.95B | $4.34B | $4.03B | $3.44B |
| Revenue growth (YoY) | +6.7% | -0.7% | +4.0% | +2.1% |
| Gross margin | 52.4% (computed) | 66.1% | 59.4% | 45.9% |
| Operating margin | 21.3% | 18.6% | n/a | 2.0% |
| Net margin | 18.8% | 19.6% | 21.6% | -0.2% |
| Net income | $1.30B | $850.00M | $869.19M | -$8.30M |
| EPS (Diluted) | $4.57 | $5.45 | $42.05 | -$0.15 |
| Operating cash flow | $1.56B | $1.08B | $955.77M | $134.10M |
| Free cash flow | $1.15B | $931.00M | $848.65M | $43.30M |
| Cash & equivalents | $1.79B | n/a | n/a | $298.80M |
| Total assets | $12.73B | $6.64B | $3.71B | $6.24B |
| Total liabilities | $5.99B | n/a | $3.74B | $3.73B |
| Shareholders' equity | $6.74B | $2.72B | -$23.64M | $2.47B |
| Return on year-end equity | 19.3% | 31.2% | n/a | -0.3% |
| Shares outstanding | 283.05M | 153.00M | 20.36M | 152.14M |
Revenue, most recent five fiscal years
| Fiscal year | Agilent Technologies, Inc. | Illumina, Inc. | Mettler Toledo International Inc | Bruker Corp |
|---|---|---|---|---|
| Latest | $6.95B Ended 2025-10-31 | $4.34B Ended 2025-12-28 | $4.03B Ended 2025-12-31 | $3.44B Ended 2025-12-31 |
| 1 year earlier | $6.51B Ended 2024-10-31 | $4.37B Ended 2024-12-29 | $3.87B Ended 2024-12-31 | $3.37B Ended 2024-12-31 |
| 2 years earlier | $6.83B Ended 2023-10-31 | $4.50B Ended 2023-12-31 | $3.79B Ended 2023-12-31 | $2.96B Ended 2023-12-31 |
| 3 years earlier | $6.85B Ended 2022-10-31 | $4.58B Ended 2023-01-01 | $3.92B Ended 2022-12-31 | $2.53B Ended 2022-12-31 |
| 4 years earlier | $6.32B Ended 2021-10-31 | $4.53B Ended 2022-01-02 | $3.72B Ended 2021-12-31 | $2.42B Ended 2021-12-31 |